Recently, the National Medical Products Administration issued a notice on measures to optimize the full lifecycle supervision and support the innovative development of high-end medical devices (hereinafter referred to as the "Notice"), fully supporting major innovations in high-end medical devices. Zhu Keli, Executive Director of the China Information Association and Founding President of the National Research Institute for New Economy, stated in an interview with reporters that the release of the "Announcement" is a major positive news for China's high-end medical device field. It focuses on innovation in cutting-edge core technologies such as brain computer interfaces, artificial intelligence, and medical robots, and puts forward specific requirements and directions, which will effectively promote the acceleration of scientific research achievements into practical products and better meet the clinical needs of patients. From the perspective of frequent policy benefits, the Announcement clearly regards medical robots, high-end medical imaging equipment, artificial intelligence medical devices, and new biomaterials medical devices as key areas for shaping the new quality and productivity of medical devices, and proposes measures such as optimizing special approval procedures, improving classification and naming principles, continuously improving standard systems, further clarifying registration and review requirements, improving communication and guidance mechanisms and expert consultation mechanisms, refining post listing regulatory requirements, strengthening post listing quality and safety monitoring, closely following industry development, promoting regulatory scientific research, and promoting global regulatory coordination. Wu Yumeng, research assistant at the Digital Business Law Research Center of Shanghai Sanda University, told reporters that the "Announcement" clearly regards medical robots and other fields as key areas for shaping the new quality and productivity of medical devices. Providing policy support can stimulate enterprises' enthusiasm for research and development investment in these cutting-edge technology fields, accelerate technological innovation and product upgrading. Since the beginning of this year, the policy side has continued to exert efforts to lay a solid foundation for the development of the high-end medical device industry. For example, in early 2025, the General Office of the State Council issued the "Opinions on Fully Deepening the Reform of Drug and Medical Device Supervision and Promoting the High quality Development of the Pharmaceutical Industry", which proposed giving priority review and approval to high-end medical equipment such as medical robots and brain computer interface devices, as well as high-end implantable medical devices. At the local level, relevant policies have also been actively introduced to provide support. For example, the "Several Measures to Support the Development of Medicine and Medical Devices in the Whole Chain of Shenzhen" released by Shenzhen proposes to focus on the development of high-end medical device products in areas such as medical robots and artificial intelligence assisted diagnostic systems. Gao Chengfei, Director of Guangzhou Tiaoyuan Marketing Consulting Management Co., Ltd., stated in an interview with reporters that under the protection of policies, China's high-end medical device technology breakthroughs and product launch speed have significantly accelerated. Medical robots, AI medical devices, and other products have partially completed commercial verification and achieved certain application results in the market. As an important track in the current global technological competition, brain computer interfaces are currently in the application testing stage and showing a thriving development trend. At present, domestic enterprises are gradually breaking through technological barriers, and the performance of some products has approached international standards. With the accelerated clinical translation of cutting-edge technologies such as brain computer interfaces and AI healthcare, the industry will further develop towards intelligence and high-end direction. ”An Guangyong, an expert from the Credit Management Committee of the All Union Mergers and Acquisitions Association, said in an interview with reporters. Zhang Yue, Chairman of Beijing Aoyou International Cultural Media Co., Ltd., stated in an interview with reporters that in recent years, the scale of China's high-end medical device market has continued to expand, with an average annual growth rate of over 20%. Among them, cutting-edge technology fields such as medical robots and artificial intelligence medical devices are showing explosive growth. With the continuous release of policy dividends, enterprises actively promote the application of technology, and the popularity of the high-end medical device track continues to rise. Listed companies in the industrial chain are comprehensively laying out in cutting-edge sub sectors such as AI healthcare and medical robots, seizing development opportunities through technological research and development and product innovation. The relevant person in charge of Xi'an International Medical Investment Co., Ltd. said that the company has built a high-level information platform, carried out Internet medical services, and took the lead in deploying DeepSeek, actively embracing digital intelligence medical reform, with a view to accelerating high-quality development and improving digital intelligence services. The relevant person in charge of Qingdao Baiyang Pharmaceutical Co., Ltd. stated that the company operates the world's first fully self shielded radiotherapy system ZAP-X Mars Boat Radiosurgical Robot, Suzhou Tongxin Medical Technology Co., Ltd.'s fully magnetic levitation artificial heart, and Beijing Madis Medical Technology Co., Ltd.'s ultrasonic electromagnetic positioning puncture guidance equipment. The relevant person in charge of Henan Xiangyu Medical Equipment Co., Ltd. stated that the company's traditional Chinese medicine moxibustion treatment machine (traditional Chinese medicine moxibustion robot) and infrared light moxibustion treatment machine (infrared light moxibustion robot) have obtained registration certificates. It is expected that 7 products will obtain medical device registration certificates and 9 products will be produced by 2025. Guo Tao, Deputy Director of the China E-commerce Expert Service Center, stated in an interview with reporters that relevant listed companies should focus on tackling key components and materials, strengthen medical engineering integration and interdisciplinary cooperation, collaborate with medical institutions, universities, and research institutes, and accelerate the transformation of achievements and product iteration. (New Society)